Abstract
The aim of this study was (1) to analyze the in situ lifetime of indwelling voice prostheses (VPs) and (2) to investigate the role of some variables on device lifetime. We conducted a retrospective clinical study of patients visiting our outpatient clinic for problems related to their VP from August 1998 to March 2006. The mean in situ VP lifetime was 180.9 days (95% CI 162.6–199.2). The mean in situ VP lifetime was 163.3 and 202.9 days in patients irradiated and not irradiated, respectively (P = 0.008). The mean in situ VP lifetime was 126.5 and 215.7 days in patients with and without endoscopic evidence of erosive-ulcerative gastroesophageal reflux disease (GERD), respectively (P < 0.001). Multivariate analysis confirmed that radiotherapy and presence of GERD significantly affected the in situ VP lifetime. This study confirmed the relationship between short VP lifetime and radiation therapy. In addition, a possible association between GERD and limited device lifetime was identified.
Similar content being viewed by others
References
Terada T, Saeki N, Toh K, Uwa N, Sagawa K, Takayasu S, Sakagami M (2007) Voice rehabilitation with Provox2 voice prosthesis following total laryngectomy for laryngeal and hypopharyngeal carcinoma. Auris Nasus Larynx 34:65–71
Hilgers FJ, Cornelissen MW, Balm AJ (1993) Aerodynamic characteristics of the Provox low-resistance indwelling voice prosthesis. Eur Arch Otorhinolaryngol 250:375–378
Hilgers FJ, Ackerstaff AH, Balm AJ, Van den Brekel MW, Bing Tan I, Persson JO (2003) A new problem-solving indwelling voice prosthesis, eliminating the need for frequent Candida- and “underpressure”-related replacements: Provox ActiValve. Acta Otolaryngol 123:972–979
Elving GJ, van der Mei HC, Busscher HJ, van Weissenbruch R, Albers FW (2002) Comparison of the microbial composition of voice prosthesis biofilms from patients requiring frequent versus infrequent replacement. Ann Otol Rhinol Laryngol 111:200–203
Shultz JR, Harrison J (1992) Defining and predicting tracheoesophageal puncture success. Arch Otolaryngol Head Neck Surg 118:811–816
Kao WW, Mohr RM, Kimmel CA, Getch C, Silverman C (1994) The outcome and techniques of primary and secondary tracheoesophageal puncture. Arch Otolaryngol Head Neck Surg 120:301–307
Makitie AA, Niemensivu R, Juvas A, Aaltonen LM, Back L, Lehtonen H (2003) Postlaryngectomy voice restoration using a voice prosthesis: a single institution’s ten-year experience. Ann Otol Rhinol Laryngol 112:1007–1010
Elving GJ, Van Weissenbruch R, Busscher HJ, Van Der Mei HC, Albers FW (2002) The influence of radiotherapy on the lifetime of silicone rubber voice prostheses in laryngectomized patients. Laryngoscope 112:1680–1683
Delsupehe K, Zink I, Lejaegere M, Delaere P (1998) Prospective randomized comparative study of tracheoesophageal voice prosthesis: Blom–Singer versus Provox. Laryngoscope 108:1561–1565
Laccourreye O, Menard M, Crevier-Buchman L, Couloigner V, Brasnu D (1997) In situ lifetime, causes for replacement, and complications of the Provox voice prosthesis. Laryngoscope 107:527–530
Op de Coul BM, Hilgers FJ, Balm AJ, Tan IB, van den Hoogen FJ, van Tinteren H (2000) A decade of postlaryngectomy vocal rehabilitation in 318 patients: a single Institution’s experience with consistent application of provox indwelling voice prostheses. Arch Otolaryngol Head Neck Surg 126:1320–1328
Demir D, Suoglu Y, Emin H, Guven M, Kiyak E (2004) Factors that affect in situ lifetime of Provox voice prosthesis. Kulak Burun Bogaz Ihtis Derg 13:126–131
Leder SB, Erskine MC (1997) Voice restoration after laryngectomy: experience with the Blom–Singer extended-wear indwelling tracheoesophageal voice prosthesis. Head Neck 19:487–93
Holmes AR, van der Wielen P, Cannon RD, Ruske D, Dawes P (2006) Candida albicans binds to saliva proteins selectively adsorbed to silicone. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102:488–494
Ameye D, Honraet K, Loose D, Vermeersch H, Nelis H, Remon JP (2005) Effect of a buccal bioadhesive nystatin tablet on the lifetime of a Provox silicone tracheoesophageal voice prosthesis. Acta Otolaryngol 125:304–306
Schwandt LQ, van Weissenbruch R, van der Mei HC, Busscher HJ, Albers FW (2005) Effect of dairy products on the lifetime of Provox2 voice prostheses in vitro and in vivo. Head Neck 27:471–477
Leder SB, Acton LM, Kmiecik J, Ganz C, Blom ED (2005) Voice restoration with the advantage tracheoesophageal voice prosthesis. Otolaryngol Head Neck Surg 133:681–684
Liu RP, Fleming TJ, Toth BB, Keene HJ (1990) Salivary flow rates in patients with head and neck cancer 0.5 to 25 years after radiotherapy. Oral Surg Oral Med Oral Pathol 70:724–729
Lundell L (2007) Therapy of gastroesophageal reflux: evidence-based approach to antireflux surgery. Dig Dis 25:188–196
Smout AJ (2007) The patient with GORD and chronically recurrent problems. Best Pract Res Clin Gastroenterol 21:365–378
Metz DC, Inadomi JM, Howden CW, van Zanten SJ, Bytzer P (2007) On-demand therapy for gastroesophageal reflux disease. Am J Gastroenterol 102:642–653
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Boscolo-Rizzo, P., Marchiori, C., Gava, A. et al. The impact of radiotherapy and GERD on in situ lifetime of indwelling voice prostheses. Eur Arch Otorhinolaryngol 265, 791–796 (2008). https://doi.org/10.1007/s00405-007-0536-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-007-0536-1